NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Bamboo Therapeutics, Inc., a recently formed biotechnology company focused on advancing therapies for rare pediatric diseases of the central and neuromuscular systems, and CureDuchenne, a nonprofit organization dedicated to funding research and improving patient care for Duchenne muscular dystrophy, will host a webinar “Bamboo Therapeutics – Developing a novel gene therapy for patients with Duchenne Muscular Dystrophy” on Monday, June 13 at 3 p.m. ET/noon PT.
